2025 has proven to be another year of monumental change for the life sciences industry and 2026 promises to build on that momentum.
From changing regulations and economic landscapes to looming tariffs and budget constraints, pharmaceutical and medical device organizations have needed to look for ways to reduce costs and drive efficiency across all elements of their business. These changes have gone hand-in-hand with the rapid acceleration of data democratization and adoption of AI across R&D, clinical, manufacturing and commercial functions of the business.
Watch this webinar to hear perspectives from life sciences industry leaders on how data and AI will continue to shape the landscape for life sciences organizations in 2026 and beyond.